From: chemistry-request at ccl.net
To: chemistry-request at ccl.net
Date: Sat Oct 13 14:00:01 2007
Subject: 08.03.18 2008 AMIA Summit on Translational Bioinformatics, San Francisco, California
2008 AMIA Summit on Translational Bioinformatics InterContinental Mark Hopkins San Francisco San Francisco, California March 10-12, 2008 http://www.amia.org/meetings/stb08/ In 2005, Dr. Elias Zerhouni, Director of the National Institutes of Health (NIH), wrote in the New England Journal of Medicine: "It is the responsibility of those of us involved in today's biomedical research enterprise to translate the remarkable scientific innovations we are witnessing into health gains for the nation... At no other time has the need for a robust, bidirectional information flow between basic and translational scientists been so necessary." In that publication, Dr. Zerhouni introduced his ideas to re-engineer the way clinical research was performed in the United States. With the doubling of the NIH budget in the past decade, and coincident completion of the Human Genome Project, there is a perceived need to translate products of the genome era into products for clinical care. The push to reinvent clinical research culminated in the release of the NIH Roadmap Request for Applications (RFA) for Institutional Clinical and Translational Science Awards (CTSA). Twelve academic health centers were awarded during the first round of funding. Clearly evident in Dr. Zerhouni's quote is the role biomedical informatics needs to play in facilitating translational medicine. Indeed, the RFA for the CTSA itself mentions the term "informatics" more than thirty times. The American Medical Informatics Association (AMIA) recently added Translational Bioinformatics as one of its three major domains of informatics. AMIA defines Translational Bioinformatics as: "the development of storage, analytic, and interpretive methods to optimize the transformation of increasingly voluminous biomedical data into proactive, predictive, preventative, and participatory health. Translational bioinformatics includes research on the development of novel techniques for the integration of biological and clinical data and the evolution of clinical informatics methodology to encompass biological observations. The end product of translational bioinformatics is newly found knowledge from these integrative efforts that can be disseminated to a variety of stakeholders, including biomedical scientists, clinicians, and patients." While the call for translational bioinformaticians was issued by none other than the Director of the NIH, and while translational bioinformatics is now one of AMIA's major domains of informatics, currently there is no national annual conference or symposium for the presentation and discussion of research work in Translational Bioinformatics. This will change in 2008 with the inaugural Summit on Translational Bioinformatics conducted by the American Medical Informatics Association. We will leverage AMIA's proficiency in managing large events, but I can also promise the dissemination and sharing of knowledge at this event will in many ways look unlike a traditional AMIA meeting with the presentation of research showcasing the synergy between the medical informatics and bioinformatics communities. While we anticipate that non-research issues relating to translational bioinformatics and clinical research informatics will be a continuing part of the Spring Congress and Annual Symposium, the deficiency exists for an American conference covering the entire domain of bioinformatics and computational biology. Here we endeavor to hold a summit covering the more specific and tractable need of Translational Bioinformatics, which is more directly relevant to the interests of AMIA. I would like to invite the submission of manuscripts including scientific papers, posters, and panels. The specifications for each category follow. The deadline for submission is Monday, September 17, 2007. We will publish a Proceedings of the summit and will upload the accepted peer-reviewed papers into PubMedCentral. I do hope you will save the dates of March 10-12, 2008 and plan to travel to San Francisco, California, to attend what we believe will be the first of many meetings with a singular focus on translational bioinformatics. Sincerely, Atul Butte, MD, PhD Categories of Submission The types of submissions considered and general requirements for each are listed on these pages. All submissions must conform to the format and presentation requirements described herein, and at the AMIA submission site. Visit www.amia.org and select the submission link for the Summit on Translational Bioinformatics 2008. Papers The Scientific Program Committee (SPC) solicits papers on the latest progress on using informatics approaches to improve translational biomedical research. Authors of accepted papers will have 15 minutes to present their work at the symposium with five minutes for questions and discussion. An individual may be a first author of only one paper submitted for consideration. Submissions must not be in press or under consideration for presentation or publication elsewhere. Paper submissions must not exceed a maximum of five (8.5 x 11 inch) pages and must include: * An abstract of 125-150 words * The names, academic degree(s), affiliations, and locations (city, state, and country, if international) of all authors Posters Posters are the preferred format for presenting preliminary research results or results of small scale studies, illustrating and discussing innovative systems and services, describing experimental and in-practice projects and programs, reporting experiences with educational programs, and other dimensions of translational bioinformatics. Poster sessions are a component of the summit designed to offer direct access to the authors in a way not possible through podium presentations. Each accepted poster is displayed during a 90-minute poster session. At least one author must be present at the poster session. Electrical power is not supplied to individual posters at the time of the presentation. An individual may be a first author of only one proposal for a poster presentation. Poster proposals must be submitted as a one-page (8.5 x 11 inch) document and must include: * An abstract of 50-75 words summarizing the submission * A description of the problem addressed and specific purposes of the system, service, or project; or, in the case of original research, an overview of the methodology, evaluation results, and conclusions * The names, academic degree(s), affiliations, and locations (city, state, and country, if international) of all authors Panels Panel topics may be on a specific aspect of theory, application, or experience pertaining to any aspect of biomedical or health informatics, or may provide interdisciplinary viewpoints that cut across traditional themes. Panels should be limited to four participants and a moderator. Panel sessions will typically consist of four 15 minute presentations, each followed by 5 minutes of questions, with 10 minutes for closing discussion. An individual may be the primary organizer of only one panel, and may not participate on more than two panels total. Panel proposals must not exceed a maximum of three (8.5 x 11 inch) pages and must include: * An abstract of 150-200 words, describing the panel, that will serve as the basis for a description in the on-line and print programs * A general description of the panel and issue(s) that will be examined * A brief description of each panelists presentation * The names, academic degree(s), affiliations, and locations (city, state, and country, if international) of the panel organizer and all participants * A statement included at the conclusion of the proposal by the panel organizer that all participants have agreed to take part on the panel Summit Co-sponsor AMIA, 4915 St. Elmo Avenue, Suite 401, Bethesda, MD 20814, phone:301-657-1291, fax:301-657-1296, mail[]amia.orgNOTE THAT E-MAIL ADDRESSES HAVE BEEN MODIFIED!!!